Gamma-hydroxybutyric acid versus naltrexone in maintaining alcohol abstinence: an open randomized comparative study

Fabio Caputo(University of Bologna), Mauro Bernardi(Universidad Nacional de La Pampa), Marco Domenicali(University of Bologna), Antonio Gasbarrini(Università Cattolica del Sacro Cuore), Giovanni Addolorato(Università Cattolica del Sacro Cuore), Francesca Lorenzini(University of Bologna), Giovanni Greco(University of Naples Federico II), Arfedele Del Re(University of Bologna), G.F. Stefanini(Ospedale degli Infermi)

Drug and Alcohol Dependence

April 7, 2003

10.1016/s0376-8716(02)00340-x

Cited by 76

Related Papers

Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019

|Journal of the American College of Cardiology|2020|11.1k

Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

|The Lancet|2024|4.4k

Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021

|The Lancet|2024|931

Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites

|Journal of Hepatology|2015|864

Commensal Clostridia: leading players in the maintenance of gut homeostasis

|Gut Pathogens|2013|753